Terms: = Lung cancer AND XPC, XP3, 7508, ENSG00000154767, XPCC
98 results:
1. Genetic Variants Associated With Response to Platinum-Based Chemotherapy in Non-Small Cell lung cancer Patients: A Field Synopsis and Meta-Analysis.
Sito H; Sharzehan MAK; Islam MA; Tan SC
Br J Biomed Sci; 2024; 81():11835. PubMed ID: 38450253
[No Abstract] [Full Text] [Related]
2. Single-nucleotide polymorphisms of nucleotide excision repair genes and their association with overall survival in North Indian lung cancer patients treated with platinum-based doublet chemotherapy.
Singh S; Sharma S; Lawania S; Singh N
J Cancer Res Ther; 2023; 19(2):408-419. PubMed ID: 37006075
[TBL] [Abstract] [Full Text] [Related]
3. Germline pathogenic variants in patients with early-onset neuroendocrine neoplasms.
Riechelmann RP; Donadio MDS; Jesus VHF; de Carvalho NA; Santiago KM; Barros MJ; Lopes L; Oliveira Dos Santos G; Nirvana Formiga M; Carraro DM; Torrezan GT
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36947458
[TBL] [Abstract] [Full Text] [Related]
4. New pathogenic germline variants identified in mesothelioma.
Belcaid L; Bertelsen B; Wadt K; Tuxen I; Spanggaard I; Højgaard M; Benn Sørensen J; Ravn J; Lassen U; Cilius Nielsen F; Rohrberg K; Westmose Yde C
Lung Cancer; 2023 May; 179():107172. PubMed ID: 36944283
[TBL] [Abstract] [Full Text] [Related]
5. A review on the genetic polymorphisms and susceptibility of cancer patients in Bangladesh.
Babu G; Bin Islam S; Khan MA
Mol Biol Rep; 2022 Jul; 49(7):6725-6739. PubMed ID: 35277785
[TBL] [Abstract] [Full Text] [Related]
6. DNA Repair Capacity for Personalizing Risk and Treatment Response - Assay Development and Optimization in Human Peripheral Blood Mononuclear Cells (PBMCs).
Nasrallah NA; Zhou H; Smith PA; Sears CR
DNA Repair (Amst); 2022 Mar; 111():103274. PubMed ID: 35085879
[TBL] [Abstract] [Full Text] [Related]
7. Hsa_circ_0069244 acts as the sponge of miR-346 to inhibit non-small cell lung cancer progression by regulating xpc expression.
Shi J; Wang H; Feng W; Huang S; An J; Wang L; Jiang J
Hum Cell; 2021 Sep; 34(5):1490-1503. PubMed ID: 34228324
[TBL] [Abstract] [Full Text] [Related]
8. Downregulation of Xeroderma Pigmentosum Complementation Group C Expression by 17-Allylamino-17-Demethoxygeldanamycin Enhances Bevacizumab-Induced Cytotoxicity in Human lung cancer Cells.
Chen JC; Ko JC; Taso YC; Cheng HH; Chen TY; Yen TC; Lin YW
Pharmacology; 2021; 106(3-4):154-168. PubMed ID: 33202406
[TBL] [Abstract] [Full Text] [Related]
9. Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated xpc transcription.
Liu Y; Wang X; Li W; Xu Y; Zhuo Y; Li M; He Y; Wang X; Guo Q; Zhao L; Qiang L
Oncogene; 2020 Nov; 39(45):6893-6905. PubMed ID: 32978517
[TBL] [Abstract] [Full Text] [Related]
10. Genetic polymorphisms of GSTP1, XRCC1, xpc and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh.
Bushra MU; Rivu SF; Sifat AE; Nahid NA; Ahmed MU; Al-Mamun MMA; Apu MNH; Islam MS; Islam MR; Islam MS; Hasnat A
Mol Biol Rep; 2020 Sep; 47(9):7073-7082. PubMed ID: 32880833
[TBL] [Abstract] [Full Text] [Related]
11. Overexpression of
Tran OT; Tadesse S; Chu C; Kidane D
Tumour Biol; 2020 May; 42(5):1010428320918404. PubMed ID: 32364878
[TBL] [Abstract] [Full Text] [Related]
12. Polymorphisms in DNA repair genes in lung cancer patients living in a coal-mining region.
Minina VI; Bakanova ML; Soboleva OA; Ryzhkova AV; Titov RA; Savchenko YA; Sinitsky MY; Voronina EN; Titov VA; Glushkov AN
Eur J Cancer Prev; 2019 Nov; 28(6):522-528. PubMed ID: 31584889
[TBL] [Abstract] [Full Text] [Related]
13. The multi-faceted high order polymorphic synergistic interactions among nucleotide excision repair genes increase the risk of lung cancer in North Indians.
Lawania S; Singh A; Sharma S; Singh N; Behera D
Mutat Res; 2019 Nov; 816-818():111673. PubMed ID: 31195348
[TBL] [Abstract] [Full Text] [Related]
14. DNA repair as an emerging target for COPD-lung cancer overlap.
Sears CR
Respir Investig; 2019 Mar; 57(2):111-121. PubMed ID: 30630751
[TBL] [Abstract] [Full Text] [Related]
15. xpc inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
[TBL] [Abstract] [Full Text] [Related]
16. xpc protects against smoking- and carcinogen-induced lung adenocarcinoma.
Zhou H; Saliba J; Sandusky GE; Sears CR
Carcinogenesis; 2019 May; 40(3):403-411. PubMed ID: 30624620
[TBL] [Abstract] [Full Text] [Related]
17. Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, xpc, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine.
Mlak R; Krawczyk P; Homa-Mlak I; Powrózek T; Ciesielka M; Kozioł P; Milanowski J; Małecka-Massalska T
Pathol Oncol Res; 2019 Jul; 25(3):1035-1045. PubMed ID: 30066234
[TBL] [Abstract] [Full Text] [Related]
18. 17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human lung Squamous Cell Carcinoma Cells.
Chen JC; Ma PF; Lin YC; Wu CH; Peng YS; Zheng HY; Lin MC; Li YT; Lin YW
Pharmacology; 2018; 102(1-2):91-104. PubMed ID: 29953987
[TBL] [Abstract] [Full Text] [Related]
19. Aldehydes are the predominant forces inducing DNA damage and inhibiting DNA repair in tobacco smoke carcinogenesis.
Weng MW; Lee HW; Park SH; Hu Y; Wang HT; Chen LC; Rom WN; Huang WC; Lepor H; Wu XR; Yang CS; Tang MS
Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6152-E6161. PubMed ID: 29915082
[TBL] [Abstract] [Full Text] [Related]
20. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells.
Lee HW; Park SH; Weng MW; Wang HT; Huang WC; Lepor H; Wu XR; Chen LC; Tang MS
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1560-E1569. PubMed ID: 29378943
[TBL] [Abstract] [Full Text] [Related]
[Next]
